Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by S. Feyler
The Requirement for DNAM-1, NKG2D, and NKp46 in the Natural Killer Cell-Mediated Killing of Myeloma Cells
Cancer Research
Cancer Research
Oncology
Related publications
DNAM-1: Would the Real Natural Killer Cell Please Stand Up!
Oncotarget
Oncology
Human microRNA-1245 Down-Regulates the NKG2D Receptor in Natural Killer Cells and Impairs NKG2D-mediated Functions
Haematologica
Hematology
Proteasome Inhibition Induces Apoptosis in Primary Human Natural Killer Cells and Suppresses NKp46-mediated Cytotoxicity
Haematologica
Hematology
Costimulatory Molecule DNAM-1 Is Essential for Optimal Differentiation of Memory Natural Killer Cells During Mouse Cytomegalovirus Infection
Immunity
Infectious Diseases
Allergy
Immunology
Enhancing Natural Killer Cell-Mediated Lysis of Lymphoma Cells by Combining Therapeutic Antibodies With CD20-Specific Immunoligands Engaging NKG2D or NKp30
Blood
Biochemistry
Immunology
Cell Biology
Hematology
Natural Cytotoxicity Triggering Receptor 1 (NCR1; NKP46; CD335); Natural Killer P30 Receptor (NKp30; NCR3; CD337)
Science-Business eXchange
NKG2D-mediated Natural Killer Cell Protection Against Cytomegalovirus Is Impaired by Viral Gp40 Modulation of Retinoic Acid Early Inducible 1 Gene Molecules
Journal of Experimental Medicine
Medicine
Allergy
Immunology
Circulating NKp46+ Natural Killer Cells Have a Potential Regulatory Property and Predict Distinct Survival in Non-Small Cell Lung Cancer
OncoImmunology
Oncology
Allergy
Immunology
Adoptive Transfer of NKG2D CAR mRNA-Engineered Natural Killer Cells in Colorectal Cancer Patients
Molecular Therapy
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery
